ZNF8
gene geneOn this page
Also known as HF.18Zfp128
Summary
ZNF8 (zinc finger protein 8, HGNC:13154) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 8 (P17098). Transcriptional repressor.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II. Predicted to act upstream of or within BMP signaling pathway. Predicted to be active in nucleus.
Source: NCBI Gene 7554 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 86 total
- MANE Select transcript:
NM_021089
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13154 |
| Approved symbol | ZNF8 |
| Name | zinc finger protein 8 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HF.18, Zfp128 |
| Ensembl gene | ENSG00000278129 |
| Ensembl biotype | protein_coding |
| OMIM | 194532 |
| Entrez | 7554 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000621650, ENST00000914383
RefSeq mRNA: 1 — MANE Select: NM_021089
NM_021089
CCDS: CCDS12974
Canonical transcript exons
ENST00000621650 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001337661 | 58278955 | 58279147 |
| ENSE00003717446 | 58286110 | 58286205 |
| ENSE00003723656 | 58294098 | 58302791 |
| ENSE00003726946 | 58285717 | 58285843 |
Expression profiles
Bgee: expression breadth ubiquitous, 233 present calls, max score 84.05.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0360 / max 64.1693, expressed in 1733 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177823 | 7.7691 | 1729 |
| 177824 | 0.2669 | 126 |
Top tissues by expression
280 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| parotid gland | UBERON:0001831 | 84.05 | gold quality |
| cortical plate | UBERON:0005343 | 80.62 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.31 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.27 | gold quality |
| ventricular zone | UBERON:0003053 | 76.78 | gold quality |
| caput epididymis | UBERON:0004358 | 75.91 | gold quality |
| cauda epididymis | UBERON:0004360 | 75.66 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.52 | gold quality |
| corpus epididymis | UBERON:0004359 | 75.30 | gold quality |
| cartilage tissue | UBERON:0002418 | 74.18 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.91 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 73.86 | gold quality |
| sperm | CL:0000019 | 72.72 | silver quality |
| tibia | UBERON:0000979 | 72.24 | silver quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 72.08 | silver quality |
| embryo | UBERON:0000922 | 72.01 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 71.54 | gold quality |
| male germ cell | CL:0000015 | 71.35 | silver quality |
| germinal epithelium of ovary | UBERON:0001304 | 70.93 | gold quality |
| pancreatic ductal cell | CL:0002079 | 70.47 | silver quality |
| bronchial epithelial cell | CL:0002328 | 70.43 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 70.41 | gold quality |
| primary visual cortex | UBERON:0002436 | 70.33 | gold quality |
| cerebellar cortex | UBERON:0002129 | 70.31 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 70.22 | gold quality |
| endothelial cell | CL:0000115 | 70.19 | gold quality |
| cerebellum | UBERON:0002037 | 70.14 | gold quality |
| colonic epithelium | UBERON:0000397 | 70.12 | gold quality |
| entorhinal cortex | UBERON:0002728 | 70.05 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 69.45 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.41 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| BMP1 | Repression |
| TGFB1 | Repression |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1718.1 | ZNF8 | Factors with multiple dispersed zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28273063
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
12 targeting ZNF8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-128-1-5P | 99.33 | 60.46 | 332 |
| HSA-MIR-128-2-5P | 99.33 | 60.83 | 311 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
| HSA-MIR-9898 | 99.00 | 67.89 | 500 |
| HSA-MIR-154-5P | 98.92 | 66.65 | 733 |
| HSA-MIR-519A-2-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-520B-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-6769B-5P | 98.73 | 64.91 | 1092 |
| HSA-MIR-6769A-5P | 97.99 | 64.16 | 851 |
Literature-anchored findings (GeneRIF, showing 3)
- ZNF8-miR-552-5p Axis Modulates ACSL4-Mediated Ferroptosis in Hepatocellular Carcinoma. (PMID:37126948)
- ZNF8 promotes progression of gastrointestinal cancers via a p53-dependent mechanism. (PMID:39173856)
- ZNF8 Orchestrates with Smad3 to Promote Lung Metastasis by Recruiting SMYD3 in Breast Cancer. (PMID:39225541)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp128 | ENSMUSG00000060397 |
| rattus_norvegicus | LOC108348304 | ENSRNOG00000031459 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343)
Protein
Protein identifiers
Zinc finger protein 8 — P17098 (reviewed: P17098)
Alternative names: Zinc finger protein HF.18
All UniProt accessions (1): P17098
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor. May modulate BMP and TGF-beta signal transduction, through its interaction with SMAD proteins.
Subunit / interactions. Interacts with SMAD1 (via MH1 and MH2 domains). Interacts with SMAD5. Interacts weakly with SMAD2. Interacts weakly with SMAD3 and SMAD4.
Subcellular location. Nucleus.
Tissue specificity. Ubiquitously present in many human cell lines of different embryological derivation.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_066575* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (22 total): zinc finger region 7, cross-link 4, region of interest 3, compositionally biased region 3, sequence conflict 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17098-F1 | 58.52 | 0.03 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 174, 249, 441, 545
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 95 (showing top):
BROWNE_HCMV_INFECTION_6HR_DN, GCM_MYCL1, GCM_RING1, GCM_FCGR2B, GCM_DPF2, WTGAAAT_UNKNOWN, GCM_TEC, GCM_CDH5, KAYO_AGING_MUSCLE_UP, GCM_LTK, GCM_BECN1, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GCM_BNIP1, VERHAAK_GLIOBLASTOMA_CLASSICAL
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), BMP signaling pathway (GO:0030509), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| cellular response to BMP stimulus | 1 |
| transforming growth factor beta receptor superfamily signaling pathway | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
670 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF8 | ZNF385B | Q569K4 | 488 |
| ZNF8 | ZNF827 | Q17R98 | 473 |
| ZNF8 | GARIN6 | Q8NEG0 | 467 |
| ZNF8 | TSHZ3 | Q63HK5 | 464 |
| ZNF8 | HORMAD2 | Q8N7B1 | 402 |
| ZNF8 | A0A0U1RQV1 | A0A0U1RQV1 | 373 |
| ZNF8 | HORMAD1 | Q86X24 | 362 |
| ZNF8 | RSPRY1 | Q96DX4 | 359 |
| ZNF8 | ZBTB3 | Q9H5J0 | 354 |
| ZNF8 | EWSR1 | Q01844 | 352 |
| ZNF8 | MSH3 | P20585 | 349 |
| ZNF8 | LIMS3 | P0CW19 | 349 |
| ZNF8 | ERVFRD-1 | P60508 | 349 |
| ZNF8 | MSH6 | P52701 | 348 |
| ZNF8 | FBLN2 | P98095 | 333 |
IntAct
31 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF8 | TRIM28 | psi-mi:“MI:0914”(association) | 0.730 |
| ZNF8 | AP1M1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF8 | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF8 | MCRS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VWCE | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| TIMM50 | ZNF724 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| Trim28 | FTH1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CBX5 | ZNF568 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX3 | KPNA4 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF8 | TRIM24 | psi-mi:“MI:0914”(association) | 0.350 |
| WEE1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| MAD2L1 | MED19 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN5 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| KCNA4 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| PTX3 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF8 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| PTX3 | OFD1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF8 | NFX1 | psi-mi:“MI:0914”(association) | 0.350 |
| H2BC10 | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| AP1M1 | ZNF8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF114 | ZNF8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MCRS1 | ZNF8 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (80): ZNF8 (Affinity Capture-RNA), ZNF8 (Affinity Capture-RNA), ZNF8 (Proximity Label-MS), ZNF8 (Affinity Capture-MS), ZNF8 (Affinity Capture-RNA), ZNF8 (Two-hybrid), ZNF8 (Two-hybrid), ZNF8 (Two-hybrid), ZNF8 (Affinity Capture-MS), ZNF8 (Positive Genetic), ZNF8 (Proximity Label-MS), ZNF8 (Proximity Label-MS), ZNF8 (Proximity Label-MS), ZNF8 (Affinity Capture-MS), ZNF8 (Affinity Capture-MS)
ESM2 similar proteins: A1A5P9, A2AVR2, A6QPT6, B2KFW1, O14978, P17029, P17040, P17098, P25233, P70503, Q13342, Q14D33, Q3SYK4, Q3V3Q4, Q4KLI1, Q4R8H9, Q4V8E9, Q5PPP4, Q5R670, Q5R7U0, Q5VWK0, Q61066, Q63HK3, Q68CQ1, Q6PCZ4, Q7TS72, Q80ZG2, Q8BGS3, Q8CF60, Q8IWY8, Q8N660, Q8NDZ0, Q8TD17, Q921B4, Q923B3, Q96D09, Q96GC6, Q96JL9, Q96M43, Q99608
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
86 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 79 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
955 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:58285713:TCAGG:T | acceptor_loss | 1.0000 |
| 19:58285714:CAG:C | acceptor_loss | 1.0000 |
| 19:58285714:CAGG:C | acceptor_loss | 1.0000 |
| 19:58285715:A:AG | acceptor_gain | 1.0000 |
| 19:58285715:AGGA:A | acceptor_loss | 1.0000 |
| 19:58285716:G:GC | acceptor_loss | 1.0000 |
| 19:58285716:G:GG | acceptor_gain | 1.0000 |
| 19:58285840:ATAGG:A | donor_gain | 1.0000 |
| 19:58285841:TAGG:T | donor_gain | 1.0000 |
| 19:58285841:TAGGT:T | donor_gain | 1.0000 |
| 19:58285842:AGGTA:A | donor_gain | 1.0000 |
| 19:58285843:GGTAA:G | donor_gain | 1.0000 |
| 19:58285844:G:C | donor_gain | 1.0000 |
| 19:58285844:G:GA | donor_gain | 1.0000 |
| 19:58285844:G:GG | donor_gain | 1.0000 |
| 19:58285845:T:A | donor_gain | 1.0000 |
| 19:58286102:A:AG | acceptor_gain | 1.0000 |
| 19:58286103:T:G | acceptor_gain | 1.0000 |
| 19:58286105:TCCA:T | acceptor_loss | 1.0000 |
| 19:58286106:CCAG:C | acceptor_loss | 1.0000 |
| 19:58286107:CAG:C | acceptor_loss | 1.0000 |
| 19:58286107:CAGG:C | acceptor_loss | 1.0000 |
| 19:58286108:A:AG | acceptor_gain | 1.0000 |
| 19:58286108:A:T | acceptor_loss | 1.0000 |
| 19:58286108:AG:A | acceptor_gain | 1.0000 |
| 19:58286108:AGGTC:A | acceptor_loss | 1.0000 |
| 19:58286109:G:GG | acceptor_gain | 1.0000 |
| 19:58286109:G:GT | acceptor_gain | 1.0000 |
| 19:58286109:GG:G | acceptor_gain | 1.0000 |
| 19:58286109:GGT:G | acceptor_gain | 1.0000 |
AlphaMissense
3808 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:58294688:T:C | F294L | 1.000 |
| 19:58294690:C:A | F294L | 1.000 |
| 19:58294690:C:G | F294L | 1.000 |
| 19:58294772:T:C | F322L | 1.000 |
| 19:58294774:C:A | F322L | 1.000 |
| 19:58294774:C:G | F322L | 1.000 |
| 19:58294856:T:C | F350L | 1.000 |
| 19:58294858:C:A | F350L | 1.000 |
| 19:58294858:C:G | F350L | 1.000 |
| 19:58294940:T:C | F378L | 1.000 |
| 19:58294942:C:A | F378L | 1.000 |
| 19:58294942:C:G | F378L | 1.000 |
| 19:58294604:T:C | F266L | 0.999 |
| 19:58294605:T:C | F266S | 0.999 |
| 19:58294606:T:A | F266L | 0.999 |
| 19:58294606:T:G | F266L | 0.999 |
| 19:58294623:T:C | L272P | 0.999 |
| 19:58294631:C:G | H275D | 0.999 |
| 19:58294689:T:C | F294S | 0.999 |
| 19:58294715:C:G | H303D | 0.999 |
| 19:58294717:T:A | H303Q | 0.999 |
| 19:58294717:T:G | H303Q | 0.999 |
| 19:58294722:G:C | R305P | 0.999 |
| 19:58294773:T:C | F322S | 0.999 |
| 19:58294791:T:C | L328P | 0.999 |
| 19:58294799:C:G | H331D | 0.999 |
| 19:58294807:G:C | R333S | 0.999 |
| 19:58294807:G:T | R333S | 0.999 |
| 19:58294857:T:C | F350S | 0.999 |
| 19:58294883:C:G | H359D | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000019488 (19:58286804 G>A), RS1000169333 (19:58298315 C>A), RS1000233911 (19:58290822 G>A), RS1000256372 (19:58284205 C>T), RS1000280390 (19:58293444 G>A), RS1000289380 (19:58277760 A>G), RS1000306615 (19:58278092 C>G,T), RS1000379856 (19:58278451 C>T), RS1000456361 (19:58302012 T>C), RS1000665813 (19:58296404 G>C,T), RS1000691701 (19:58284020 C>T), RS1000909682 (19:58299468 C>G), RS1001015180 (19:58296240 A>G), RS1001057067 (19:58283720 C>T), RS1001183876 (19:58299405 C>T)
Disease associations
OMIM: gene MIM:194532 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| cupric oxide | increases expression | 1 |
| resorcinol | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| abrine | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Manganese | increases expression, affects cotreatment, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD44 | HEK293 eGFP-ZNF8 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.